Intervention Review

You have free access to this content

Trypanocidal drugs for late stage, symptomatic Chagas disease (Trypanosoma cruzi infection)

  1. Maite Vallejo*,
  2. Pedro PA Reyes

Editorial Group: Cochrane Heart Group

Published Online: 16 JUL 2008

Assessed as up-to-date: 12 SEP 2010

DOI: 10.1002/14651858.CD004102.pub2

How to Cite

Vallejo M, Reyes PPA. Trypanocidal drugs for late stage, symptomatic Chagas disease (Trypanosoma cruzi infection). Cochrane Database of Systematic Reviews 2005, Issue 4. Art. No.: CD004102. DOI: 10.1002/14651858.CD004102.pub2.

Author Information

  1. Juan Badiano No. 1. Col. Seccion XVI, Instituto Nacional de Cardiología Ignacio Chávez, Tlalpan, Mexico

*Maite Vallejo, Instituto Nacional de Cardiología Ignacio Chávez, Juan Badiano No. 1. Col. Seccion XVI, Tlalpan, C.P. 14080, Mexico. maite_vallejo@yahoo.com.mx.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 16 JUL 2008

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Francisco Javier Carod-Artal, Joaquim Gascon, Chagas disease and stroke, The Lancet Neurology, 2010, 9, 5, 533

    CrossRef

  2. 2
    Margaret O Lau-Walker, Martin R Cowie, Michael Roughton, Coronary heart disease patients’ perception of their symptoms and sense of control are associated with their quality of life three years following hospital discharge, Journal of Clinical Nursing, 2009, 18, 1
  3. 3
    Conrado Fernández Rodríguez, Noelia Abdilla Bonías, María José Fabiá Valls, María del Carmen Nicolau Laparra, Consideraciones sobre la enfermedad de Chagas en España, Medicina Clínica, 2008, 131, 1, 37

    CrossRef

  4. 4
    James H. Diaz, Reply, Journal of Travel Medicine, 2008, 15, 5
  5. 5
    Arturo J Martí-Carvajal, Ricardo Hidalgo, Joey Kwong, Pharmacological interventions for treating heart failure in patients with Chagas cardiomyopathy, The Cochrane Library,